Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Enanta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 Aug 2015 Reuters Investment Profile 12 $20.00

Validea Guru Analysis Report for ENTA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

28 Aug 2015 Validea 0 $12.00

Thomson Reuters Stock Report - Enanta Pharmaceuticals Inc (ENTA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2015 Thomson Reuters Stock Report 12 $25.00

Value Graph: ENANTA PHARMA -- ENTA

28 Aug 2015 Ford Investor Services, Inc. 1 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENANTA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

28 Aug 2015 Jefferson Research 11 $20.00

ValuEngine Industry Report for Medical-Drugs(ENTA)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for ENTA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

22 Aug 2015 ValuEngine, Inc. 11 $25.00

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review

Enanta Pharmaceuticals, Inc. (ENTA) - Financial Analysis Review Summary Enanta Pharmaceuticals, Inc. (Enanta) is a biot...

21 Aug 2015 GlobalData 44 $125.00

Wright Investors Service Comprehensive Report for Enanta Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Aug 2015 Wright Reports 53 $75.00

ENTA.OQ - Event Transcript of Enanta Pharmaceuticals Inc conference call, Aug. 06, 2015 / 4:30PM ET

Edited Event Transcript of ENTA.OQ conference call, Aug. 06, 2015 / 4:30PM ET Boston, Aug 7, 2015 (Thomson StreetEvents...

06 Aug 2015 Thomson Reuters StreetEvents 9 $75.00